Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

Zorginstituut Nederland carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the outcomes of the assessment, the Executive Board of the Zorginstituut advised the Minister not to include fampridine in the insured standard package.